India Plans Project To Create Discovery Platform For Cheaper Drugs (India)
This article was originally published in PharmAsia News
Executive Summary
India's government plans a multi-faceted program for drug discovery that could develop medicines at a fraction of the cost multinational pharmaceuticals face. Until now, India has relied on drug makers in other countries to discover and develop drugs. The new plan would involve global firms, researchers and young workers in scientific laboratories. The government also plans an "open source" drug discovery program amassing the work of some of the world's best research. Under the initial project, the group would try to develop would-be drugs for tuberculosis, malaria, AIDS and other diseases. (Click here for more
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.